| 77KL | Nα, Nε-dioctanoyl lysine with an inorganic lithium counterion |
| A549 | Human lung adenocarcinoma |
| AFM | Atomic force microscopy |
| BCRJ | Rio de Janeiro cell bank |
| CI | Combination index |
| Di3a | 5′-Seleno-(phenyl)-(3-N)-5′-Seleno-(4-methylphenyl)-4-N(6-chloro-1,3,5-triazin-2-yl)-thymidine |
| DMEM | Dulbecco’s Modified Eagle’s Medium |
| DMSO | Dimethyl sulfoxide |
| DOX | Doxorubicin |
| DTX | Docetaxel |
| EPR | Enhanced permeability and retention effect |
| FBS | Fetal bovine serum |
| HPLC | High-performance liquid chromatography |
| L929 | Murine fibroblast cell line |
| MCT | Medium-chain triglycerides |
| MDR | Multidrug resistance |
| MTT | 2,5-diphenyl-3-(4,5-dimethyl- 2-thiazolyl) tetrazolium bromide |
| NCI/ADR-RES | Multidrug-resistant human ovarian carcinoma |
| NCs | PLGA nanocapsules |
| NLCs | Nanostructured lipid carriers |
| NPs | Nanoparticles |
| PBS | Phosphate-buffered saline |
| PDI | Polydispersity index |
| PLGA | Poly(lactic-co-glycolic acid) |
| SD | Standard deviation |
| SE | Standard error |
| ZP | Zeta potential |